Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review

Anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis is a rare autoimmune limbic encephalitis. As the clinical presentation of this disease is similar to other types of encephalitis most often associated with paraneoplastic process or endocrine disorder, a thorough testing for oncologica...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Stašaitytė, T. Vanagas, V. Danielius, G. Jurkevičienė, R. Balnytė
Format: Article
Language:English
Published: Vilnius University Press 2021-03-01
Series:Neurologijos seminarai
Subjects:
Online Access:https://www.journals.vu.lt/neurologijos_seminarai/article/view/27705
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593060009082880
author A. Stašaitytė
T. Vanagas
V. Danielius
G. Jurkevičienė
R. Balnytė
author_facet A. Stašaitytė
T. Vanagas
V. Danielius
G. Jurkevičienė
R. Balnytė
author_sort A. Stašaitytė
collection DOAJ
description Anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis is a rare autoimmune limbic encephalitis. As the clinical presentation of this disease is similar to other types of encephalitis most often associated with paraneoplastic process or endocrine disorder, a thorough testing for oncological or endocrine disease is necessary to correctly differentiate the diagnosis and administer appropriate treatment. We present a clinical case of a 63-year-old female patient treated in the Neurology Department of the Hospital of Lithuanian University of Health Sciences Kaunas Clinics for impairment of consciousness, probably of epileptic origin. After identifying memory problems, focal impaired awareness seizures, cognitive dysfunction, and typical brain magnetic resonance imaging changes, the diagnosis of limbic encephalitis was suspected. A thorough testing allowed to exclude paraneoplastic processes or endocrine syndromes, and the results of the cerebrospinal fluid antibody panel confirmed the diagnosis of anti-LGI1 antibody autoimmune encephalitis. Further treatment using glucocorticoids and intravenous immunoglobulin gave good results.
format Article
id doaj-art-414a49d8900347b68ec345853900ce0a
institution Kabale University
issn 1392-3064
2424-5917
language English
publishDate 2021-03-01
publisher Vilnius University Press
record_format Article
series Neurologijos seminarai
spelling doaj-art-414a49d8900347b68ec345853900ce0a2025-01-20T18:22:28ZengVilnius University PressNeurologijos seminarai1392-30642424-59172021-03-01251(87)10.29014/ns.2021.08Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature reviewA. Stašaitytė 0T. Vanagas 1V. Danielius 2G. Jurkevičienė 3R. Balnytė 4Lithuanian University of Health SciencesLithuanian University of Health SciencesLithuanian University of Health SciencesLithuanian University of Health SciencesLithuanian University of Health Sciences Anti-leucine-rich glioma inactivated 1 (anti-LGI1) encephalitis is a rare autoimmune limbic encephalitis. As the clinical presentation of this disease is similar to other types of encephalitis most often associated with paraneoplastic process or endocrine disorder, a thorough testing for oncological or endocrine disease is necessary to correctly differentiate the diagnosis and administer appropriate treatment. We present a clinical case of a 63-year-old female patient treated in the Neurology Department of the Hospital of Lithuanian University of Health Sciences Kaunas Clinics for impairment of consciousness, probably of epileptic origin. After identifying memory problems, focal impaired awareness seizures, cognitive dysfunction, and typical brain magnetic resonance imaging changes, the diagnosis of limbic encephalitis was suspected. A thorough testing allowed to exclude paraneoplastic processes or endocrine syndromes, and the results of the cerebrospinal fluid antibody panel confirmed the diagnosis of anti-LGI1 antibody autoimmune encephalitis. Further treatment using glucocorticoids and intravenous immunoglobulin gave good results. https://www.journals.vu.lt/neurologijos_seminarai/article/view/27705autoimmune encephalitisanti-LGI1 antibodyhyponatremiaseizures
spellingShingle A. Stašaitytė
T. Vanagas
V. Danielius
G. Jurkevičienė
R. Balnytė
Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
Neurologijos seminarai
autoimmune encephalitis
anti-LGI1 antibody
hyponatremia
seizures
title Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
title_full Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
title_fullStr Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
title_full_unstemmed Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
title_short Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
title_sort anti lgi1 antibody autoimmune encephalitis clinical case presentation and literature review
topic autoimmune encephalitis
anti-LGI1 antibody
hyponatremia
seizures
url https://www.journals.vu.lt/neurologijos_seminarai/article/view/27705
work_keys_str_mv AT astasaityte antilgi1antibodyautoimmuneencephalitisclinicalcasepresentationandliteraturereview
AT tvanagas antilgi1antibodyautoimmuneencephalitisclinicalcasepresentationandliteraturereview
AT vdanielius antilgi1antibodyautoimmuneencephalitisclinicalcasepresentationandliteraturereview
AT gjurkeviciene antilgi1antibodyautoimmuneencephalitisclinicalcasepresentationandliteraturereview
AT rbalnyte antilgi1antibodyautoimmuneencephalitisclinicalcasepresentationandliteraturereview